We believe strong fundamentals as scientists and strategic problem solvers drive sound recommendations across a diverse set of clients, products, and markets.

Our project portfolio in pharma and biotech strategy is expansive. Our capabilities span all stages of the product lifecycle — from early-stage opportunity assessments to inform where a product’s greatest value may lie, to comprehensive launch planning and support.

We additionally support clients in setting strategy at the franchise and corporate level — including therapeutic area strategy, licensing and acquisitions, and corporate growth strategy. We have worked in every therapeutic area, and in both developed and emerging markets.

We work with organizations big and small, from top ten pharma companies to early startups. While the solutions should be right sized for the organization, our commitment to an exceptional project experience applies to all.

We are solving the problems at new frontiers for pharma. Below, explore a few examples that spotlight our recent work.

Pipeline Discovery & Development

• MOA Mapping and Prioritization 
• Pipeline Optimization 
• Indication Prioritization 
• Product Profile Development 
• Opportunity Assessment 
• Patient Journey Assessment

Brand Launch & Lifecycle Strategy

• Demand Assessment 
• Patient & Prescriber Segmentation 
• Revenue Forecasting 
• Go-to-market Strategy 
• Global Launch Sequencing 
• Lifecycle Management

Therapeutic Area & Corporate Strategy

• Therapeutic Area Assessment 
• Portfolio Strategy 
• Competitive Intelligence 
• Corporate Growth Strategy 
• Asset Screening and Diligence 
• Buy- and Sell-side Due Diligence

Our specialized expertise allows us to understand how to overcome the distinct hurdles in the path to success for medical devices, diagnostics, and digital health products.

Emerging technologies have the potential to transform healthcare, but are in the midst of a complex transition from a physician preference and fee driven environment to a more complex, value-based care system. For medical technologies, this has created unique challenges in ensuring that product value is clearly articulated and fully realized across a range of stakeholders, from regulators, physicians, hospitals, and payers. Identifying and clearly articulating the value of innovation is important not only for early stage companies but also the large multinational players that are seeking to grow market share and their offerings.

We have extensive experience working across different medical technologies and unique situations, conducting opportunity assessments and diligences, informing commercialization and reimbursement strategies, or developing the strategic direction for a technology or business unit. Our clients span all company sizes, from small startups to large pharma, and we can tailor our expertise to best meet individual needs.

We are deeply familiar with navigating the medical technology landscape across all major developed and emerging markets, and are well-positioned to help develop global strategies to maximize product and company value.

Commercialization Support

• Opportunity Prioritization 
• Optimal Technology Application Identification 
• Indication Prioritization 
• Competitive Landscape Analysis 
• Customer Profiling & Segmentation

Market Access

• Reimbursement Strategy 
• Payer Value Proposition Assessment 
• Clinical Utility and Evidence Generation Strategy 
• Global P&MA Landscape Assessment 
• Market Entry and/or Development Strategy

Corporate Growth

• Corporate Growth Strategy 
• Business Unit Strategy 
• Adjacency Assessment 
• Buy- and Sell-side Diligence 
• Licensing and Acquisition Support

We are able to optimize pricing and access strategy through the close integration of product goals and strategies, with the realities of market-specific evidence requirements, payer goals, and competitive threats.

Our fundamentals as strategy consultants, paired with deep expertise in pricing, access, and evidence planning, uniquely position us to help our clients navigate global P&MA environments. We provide detailed, market-specific insights and P&MA strategies, and link them to broader commercial goals. This mix of P&MA and broader commercial expertise allows us to serve our clients’ market access, clinical, and commercial experts.

We work across all key major and emerging markets, providing strategic support in launch price setting and adjustments, launch sequencing, competitive entry strategy, contracting strategy, and evidence generation strategies, tailored to each market.

Our wide-ranging capabilities, deep expertise, and strategic background allow us to provide best-in-class support for P&MA challenges.

Market Access Strategy

• U.S. and Global P&MA Landscape Assessments 
• Global Launch Strategy, Sequencing, and Prioritization 
• Disruptive Trends Analysis 
• Framework Development 
• Indication Sequencing 
• Portfolio P&MA Strategy and Positioning

Pricing and Reimbursement

• Early Pricing Strategy
• Launch Pricing
• Life Cycle Management Pricing
• Innovative Pricing and Contracting Strategy
• Contract Modelling
• Gross-to-net Forecasting
• Price and Revenue Optimization Models

Diligence Support

• P&MA Due Diligence
• Assumption Pressure Testing

Value and Evidence

• Integrated HTA and Payer Evidence Planning
• Payer Value Proposition Development
• Value Driver Analysis

We combine data science with scientific and commercial expertise, incorporating analytical rigor into strategic problem-solving.

Our dedicated team of data scientists have strong technical backgrounds in statistics, computer science, or related fields, with extensive experience applying their skills specifically to key challenges within the life sciences industry.

Advanced analytics can enhance insights to address your most pressing questions. We have the flexibility to support commercial decisions across all stages of the product lifecycle and characterize the market from the perspective of all key stakeholders, to meet your specific needs.

For each engagement, we pair senior leadership, strategy consultants, and data scientists to provide comprehensive support to translate high-power computational expertise into best-in-class strategic insights.

We customize approaches, leveraging methodologies of text mining, machine learning, network analytics, web crawling, and complex data engineering, to complement our strategic insights. We work closely with our clients to identify the right data source for each engagement. Our team is deeply experienced with a wide range of healthcare data sources, including patient-level claims data, EHR/EMR data, managed markets data, and account-level sales data, among others.

Claims Data Analytics

• Patient Journey 
• Patient and Physician Segmentation 
• Epidemiology 
• Targeting Optimization

Machine Learning and Predictive Modeling

• Network Analyses 
• Rare Disease Patient Finding 
• Receptivity Modeling 
• Disease Progression Flows

Natural Language Processing / Web-scraping

• MOA Mapping 
• Influence Mapping and KOL Identification 
• Novel Target Prioritization

Payer Analytics

• Formulary Impact Analysis 
• Payer Segmentation
• Patient and Provider Services Impact

ERS provides rapid and high-quality access to carefully vetted stakeholders to directly bring you the most important market insights.

ERS manages an extensive global network that connects you with leading academic experts, high-volume prescribers, and payer and policy influencers, among other stakeholders.

We have six dedicated ERS team members who work closely with our consulting staff to customize and manage recruitment for all market research engagements. ClearView conducted more than 8,000 interviews in 2018 alone, with experts in our network located in over 40 geographies including all major established and emerging markets. Our world-class network of over 5,000 experts spans more than 45 therapeutic areas. We are constantly expanding our network reach and can perform custom recruitment for nearly any stakeholder to address your key questions.

ERS provides guidance and support across an extensive range of market research needs, from traditional telephone interviews, to surveys, in-person interviews, multi-stakeholder interviews, and live or web-based focus groups.

Example Stakeholder Types

• Clinical and scientific key opinion leaders 
• High-volume prescribers 
• Active and recent U.S. payers 
• Recent EU payer and payer experts
• Cross-functional industry experts 
• Other healthcare professions (first responders, case managers) 
• Patient advocacy groups 
• Patients and caregivers

Example Research Capabilities

• Web-assisted tele-depth interviews 
• In-person interviews 
• Quantitative surveys 
• Patient chart reviews  
• Patient journals / diary entries 
• Advisory boards 
• Live and virtual focus groups 
• Dyads and triads

ClearView Compliance Standards

ClearView maintains strict compliance procedures to ensure that all research adheres to industry best practices, recording laws, market research regulations and product safety reporting as well storage and destruction protocol. The ERS team trains each member of the consulting staff on all compliance standards and helps facilitate onboarding to your company’s specific compliance training and requirements where needed. ClearView is a member of the BHBIA and is compliant with all current interpretations of the GDPR.